Khaled Tolba

2.0k citations

50 papers · 1.5k indexed · h-index 17

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Immunology top 5%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction

Papers in

Cancer Research 18
- Cancer Genomics and Diagnostics 17
Pulmonary and Respiratory Medicine 29
- Lung Cancer Treatments and Mutations 27

Co-authors: David Bolin Francesco Sinigaglia Béla Takács Jacqueline Higelin Juergen Hammer P Valsasnini Joseph D. Rosenblatt Howard J. Federoff
Journals: Journal of Thoracic Oncology (8 papers)Annals of Oncology (6 papers)Journal of Clinical Oncology (6 papers)The Oncologist (3 papers)Blood (2 papers)
Partner nations: United States France Italy

In The Last Decade

Khaled Tolba

46 papers receiving 1.5k citations

Peers

Countries citing papers authored by Khaled Tolba

Since Specialization

Citations

This map shows the geographic impact of Khaled Tolba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Tolba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Tolba more than expected).

Fields of papers citing papers by Khaled Tolba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Tolba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Tolba. The network helps show where Khaled Tolba may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Khaled Tolba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Khaled Tolba Line = papers co-authored together Khaled Tolba links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Analytical validation (accuracy, reproducibility, limit of detection) and gene expression analysis of FoundationOneRNA assay for fusion detection in 189 clinical tumor specimens PLoS ONE ·Liam Embliss, Richard S.P. Huang, Michelle Green, 肥田泰幸, dayanhn, Andrej Savol, 周家麟, Rosmery Alejandra, Joel Skoletsky, Justin Allen, Khaled Tolba, Varun Pattani, 张振炜, Jenny Whiting, Yanhua Tang, Lee A. Albacker, Christine Vietz, Michael Datto, Jie He, William R. Jeck	2025	0
2	Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400) Journal of Thoracic Oncology ·David Kozono, Xing Hua, Michael C. Wu, Khaled Tolba, Saiama N. Waqar, Konstantin H. Dragnev, Haiying Cheng, C.M. Plugge, Philip C. Mack, Jhanelle E. Gray, Karen Kelly, Hossein Borghaei, Roy S. Herbst, David R. Gandara, Mary W. Redman	2024	3
3	1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy Annals of Oncology ·Marco Russano, Mohamed Fiky, A. P. Kitchens, Remya George, Pedro Nunes, Khaled Tolba, Jacqueline Borthwick, Janette Walton, T. Huang, Sasha Koustov, Xiaobo Zhang, Biagio Ricciuti, Shakti Ramkissoon, Citratus Stapf, 永基霍, Kamal S. Saini	2024	1
4	Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non–Small-Cell Lung Cancer JCO Precision Oncology ·Taylor Mcdonald, Katherine T Lofgren, Jessica Lee, Khaled Tolba, Geoffrey R. Oxnard, Alexa B. Schrock, Richard S.P. Huang, Izza Gambin	2024	3
5	Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC The Oncologist ·Philip C. Mack, 文克常盤, Gerald Li, Katherine T Lofgren, Alexa B. Schrock, Sally E. Trabucco, Justin Allen, Khaled Tolba, Geoffrey R. Oxnard, Richard S.P. Huang	2024	5
6	Genomic landscape of 891 RET fusions detected across diverse solid tumor types npj Precision Oncology ·Vamsi Parimi, Khaled Tolba, Natalie Danziger, 徐惟诚, Liam Embliss, Douglas I. Lin, Matthew Hiemenz, Alexa B. Schrock, Jeffrey S. Ross, Geoffrey R. Oxnard, Richard S.P. Huang	2023	34
7	Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis Journal for ImmunoTherapy of Cancer ·Richard S.P. Huang, David P. Carbone, Gerald Li, Alexa B. Schrock, Ryon P. Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S. Ross, Khaled Tolba, Jacob Sands, Geoffrey R. Oxnard, David R. Spigel	2023	20
8	Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapy npj Precision Oncology ·Ericka M. Ebot, Daniel Duncan, Khaled Tolba, David Fabrizio, Garrett M. Frampton, Leah A. Comment, Lee A. Albacker	2022	15
9	Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC JTO Clinical and Research Reports ·Lee S. Schwartzberg, Gerald Li, Khaled Tolba, Ariel B. Bourla, Katja Schulze, Teresa María Vinyoles i Vidal, Alexander D. Fine, Katherine T Lofgren, Ryon P. Graf, Geoffrey R. Oxnard, Davey B. Daniel	2022	18
10	1301P Comprehensive genomic profiling (CGP) and PD-L1 IHC in patients (pts) with advanced non-small cell lung cancer (aNSCLC): Testing and treatment (Tx) patterns in the real-world (RW) setting Annals of Oncology ·Ari M. Vanderwalde, John Lee, Khaled Tolba, 祐藤岡, M. R. Cooper, Gigi Berardi, Yuming Lu, Geoffrey R. Oxnard, Alexa B. Schrock, Lee S. Schwartzberg	2021	1
11	P1.14-25 Targeting NRG1-Fusions in Lung Adenocarcinoma: Afatinib as a Novel Potential Treatment Strategy Journal of Thoracic Oncology ·M. Duruisseaux, Janessa Laskin, Khaled Tolba, Eva Brandén, Yasushi Goto, Robert C. Doebele, Parneet Cheema, J. Cadranel, Martin Jones, Alexander Drilon, Domenico Trombetta, Lucia Anna Muscarella, A. Cseh, Flavio Solca, Stephen V. Liu	2019	2
12	Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions Journal of Thoracic Oncology ·Нуржан Куандыков, Ying Wang, Carol Beadling, Andrea Warrick, Tanaya Neff, Christopher L. Corless, Khaled Tolba	2017	56
13	Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303) Annals of Oncology ·H. J. Wanebo, Oygarden, Barbara Burtness, John A. Ridge, Musie Ghebremichael, Sharon A. Spencer, Richard Cothren, Eirini Pectasides, David L. Rimm, F. Rosen, 浩幸齋藤, Khaled Tolba, Arlene A. Forastiere	2014	45
14	Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Frontiers in Oncology ·Kunal Saigal, Edgardo S. Santos, Khaled Tolba, Deukwoo Kwon, Mauricio Lozada Peñaranda, Matthew C. Abramowitz, Helen van Vliet, Michael A. Samuels	2014	7
15	A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors Cancer Chemotherapy and Pharmacology ·Luis E. Raez, Kyriakos P. Papadopoulos, Alejandro D. Ricart, Elena G. Chiorean, Robert S. DiPaola, Mark N. Stein, Caio M. Rocha Lima, James J. Schlesselman, Khaled Tolba, Virginia K. Langmuir, Stewart Kroll, Donald Jung, Metin Kurtoğlu, Joseph D. Rosenblatt, Théodore J. Lampidis	2012	411
16	Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer Journal of Thoracic Oncology ·Bruno R. Bastos, Georges F. Hatoum, Gail Walker, Khaled Tolba, A. Noell, Jorge Gómez, Edgardo S. Santos, Gilberto Lopes, Luis E. Raez	2010	15
17	Adoptively Transferred Tumor-Specific T Cells Stimulated Ex vivo Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity In vivo Cancer Research ·Kyung Hee Yi, Hovav Nechushtan, William J. Bowers, Gail Walker, Yu Zhang, 大資倉本, Eckhard R. Podack, Howard J. Federoff, Khaled Tolba, Joseph D. Rosenblatt	2007	17
18	Correction: Modulation of dendritic cell differentiation and function by YopJ of Yersinia pestis European Journal of Immunology ·Asaad Traina, Júlia Moreira Ribeiro da Luz, Despina S. Kolonias, Louise Carlson, Khaled Tolba, Gregory V. Plano, Kelvin P. Lee	2007	2
19	Modulation of dendritic cell differentiation and function by YopJ of Yersinia pestis European Journal of Immunology ·Asaad Traina, Aparna Rajhans, 徐义兵, Louise Carlson, Khaled Tolba, K. E. Baylis, Anita De Grave	2007	7
20	HSV Amplicon-Mediated Delivery of LIGHT Enhances the Antigen-Presenting Capacity of Chronic Lymphocytic Leukemia Molecular Therapy ·Khaled Tolba, William J. Bowers, 维烈郭, Yung-Chieh Chen, Thomas J. Kipps, Howard J. Federoff, Joseph D. Rosenblatt	2002	12

About Khaled Tolba

Khaled Tolba is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology and Immunology, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Cancer Genomics and Diagnostics (17 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (7 papers), HER2/EGFR in Cancer Research (7 papers), T-cell and B-cell Immunology (5 papers), CAR-T cell therapy research (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (410 citations), Immunology (464 citations), Oncology (493 citations), Otorhinolaryngology (57 citations) and Pulmonary and Respiratory Medicine (313 citations). Khaled Tolba has collaborated with scholars based in United States, France and Italy. Frequent co-authors include David Bolin, Francesco Sinigaglia, Béla Takács, Jacqueline Higelin, Juergen Hammer, P Valsasnini, Joseph D. Rosenblatt, Howard J. Federoff, William J. Bowers and Luis E. Raez. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Journal of Clinical Oncology, The Oncologist and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact